Skip to content

Evaluation of Safety and Efficacy of TriPollar Device for Treatment of Wrinkles

Evaluation of Safety and Efficacy of TriPollar Device for Treatment of Wrinkles and Rhytides

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01858415
Enrollment
40
Registered
2013-05-21
Start date
2013-04-30
Completion date
Unknown
Last updated
2013-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Wrinkles

Brief summary

The TriPollar is intended for non invasive treatment of facial wrinkles and rhytides. This study was designed in order to evaluate the safety and efficacy of the TriPollar.

Detailed description

The TriPollar technology is based on three or more electrodes designed to deliver RF current focused into the skin, thus generating heat in the dermal layer. Selective and focused electro-heating of the skin is intended to stimulate collagen remodeling in the dermal layer resulting in non invasive wrinkle treatment.

Interventions

DEVICETriPollar

Sponsors

Pollogen
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject read, discussed and signed the Consent Form, * Healthy female/male aged 35 65 years, * Has facial wrinkles, * Capable of reading, understanding and following instructions of the procedure to be applied, * Able and willing to comply with the treatment and follow-up schedule.

Exclusion criteria

* Listed in approved protocol, and ICF

Design outcomes

Primary

MeasureTime frameDescription
Safety of TriPollar6 monthsSafety will be established by physician's assessment/observation of adverse events.
Efficacy of TriPollar6 monthsEfficacy will be established by level of wrinkle reduction at 3 m fu based on photos evaluation by independent physicians.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026